84 related articles for article (PubMed ID: 448144)
1. A role for fatty acid composition of complex cellular lipids in the susceptibility of tumor cells to humoral immune killing.
Schlager SI; Ohanian SH
J Immunol; 1979 Jul; 123(1):146-52. PubMed ID: 448144
[No Abstract] [Full Text] [Related]
2. Tumor cell lipid composition and sensitivity to humoral immune killing. II. Influence of plasma membrane and intracellular lipid and fatty acid content.
Schlager SI; Ohanian SH
J Immunol; 1980 Aug; 125(2):508-17. PubMed ID: 7391566
[No Abstract] [Full Text] [Related]
3. Correlation between the ability of tumor cells to incorporate specific fatty acids and their sensitivity to killing by a specific antibody plus guinea pig complement.
Schlager SI; Ohanian SH; Borsos T
J Natl Cancer Inst; 1978 Sep; 61(3):931-4. PubMed ID: 278869
[TBL] [Abstract][Full Text] [Related]
4. Modulation of tumor cell susceptibility to humoral immune killing through chemical and physical manipulation of cellular lipid and fatty acid composition.
Schlager SI; Ohanian SH
J Immunol; 1980 Sep; 125(3):1196-200. PubMed ID: 7410835
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of specific lipids associated with the hormone-induced resistance of tumor cells to humoral immune killing.
Schlager SI; Ohanian SH; Borsos T
J Immunol; 1979 Jan; 122(1):108-14. PubMed ID: 762409
[No Abstract] [Full Text] [Related]
6. Metabolic requirements for hormone-induced resistance to antibody-complement mediated killing of tumor cells.
Schlager SI; Ohanian SH; Borsos T
J Immunol; 1977 Sep; 119(3):789-94. PubMed ID: 894026
[TBL] [Abstract][Full Text] [Related]
7. Tumor cell lipid composition and sensitivity to humoral immune killing. I. Modification of cellular lipid and fatty acid content by metabolic inhibitors and hormones.
Schlager SI; Ohanian SH
J Immunol; 1980 Feb; 124(2):626-34. PubMed ID: 6243329
[No Abstract] [Full Text] [Related]
8. Identification of lipids synthesized and released by tumor cells under attack by antibody and complement.
Schlager SI; Ohanian SH; Borsos T
J Immunol; 1978 May; 120(5):1644-50. PubMed ID: 659869
[No Abstract] [Full Text] [Related]
9. Stimulation of the synthesis and release of lipids in tumor cells under attack by antibody and C.
Schlager SI; Ohanian SH; Borsos T
J Immunol; 1978 Mar; 120(3):895-901. PubMed ID: 632591
[TBL] [Abstract][Full Text] [Related]
10. Role of lipid fatty acyl composition and membrane fluidity in the resistance of Acholeplasma laidlawii to complement-mediated killing.
Dahl JS; Dahl CE; Levine RP
J Immunol; 1979 Jul; 123(1):104-8. PubMed ID: 448140
[No Abstract] [Full Text] [Related]
11. Effect of fatty acid modifications of cultured hepatoma cells on susceptibility to complement-mediated cytolysis.
Yoo TJ; Chiu HC; Spector AA; Whiteaker RS; Denning GM; Lee NF
Cancer Res; 1980 Apr; 40(4):1084-90. PubMed ID: 7357539
[TBL] [Abstract][Full Text] [Related]
12. Specific 125I-iodination of cell surface lipids: plasma membrane alterations induced during humoral immune attack.
Schlager SI
J Immunol; 1979 Nov; 123(5):2108-13. PubMed ID: 489973
[TBL] [Abstract][Full Text] [Related]
13. Macrophage activation for tumor cytotoxicity: analysis of cellular lipid and fatty acid content during lymphokine activation.
Schlager SI; Meltzer MS
J Reticuloendothel Soc; 1981 Mar; 29(3):227-40. PubMed ID: 7218233
[No Abstract] [Full Text] [Related]
14. Correlation between the ability of tumor cells to resist humoral immune attack and their ability to synthesize lipid.
Schlager SI; Ohanian SH; Borsos T
J Immunol; 1978 Feb; 120(2):463-71. PubMed ID: 202652
[TBL] [Abstract][Full Text] [Related]
15. Plasma membrane and intracellular lipid synthesis in tumor cells rendered resistant to humoral immune killing after treatment with hormones.
Schlager SI; Ohanian SH
J Natl Cancer Inst; 1980 Apr; 64(4):943-50. PubMed ID: 6988626
[TBL] [Abstract][Full Text] [Related]
16. Humoral immune killing of nucleated cells: mechanisms of complement-mediated attack and target cell defense.
Ohanian SH; Schlager SI
Crit Rev Immunol; 1981 Jan; 1(3):165-209. PubMed ID: 6174273
[TBL] [Abstract][Full Text] [Related]
17. Identification of lipids associated with the ability of tumor cells to resist humoral immune attack.
Schlager SI; Ohanian SH; Borsos T
J Immunol; 1978 Feb; 120(2):472-80. PubMed ID: 202653
[TBL] [Abstract][Full Text] [Related]
18. Kinetics of hormone-induced tumor cell resistance to killing by antibody and complement.
Schlager SI; Ohanian SH; Borsos T
Cancer Res; 1977 Mar; 37(3):765-70. PubMed ID: 189914
[TBL] [Abstract][Full Text] [Related]
19. Effect of catalytic hydrogenation of cellular lipid and fatty acid on the susceptibility of tumor cells to humoral immune killing.
Schlager SI
Methods Enzymol; 1981; 73(Pt B):191-9. PubMed ID: 7300678
[No Abstract] [Full Text] [Related]
20. Susceptibility of mammary tumor cells to complement-mediated cytolysis after in vitro or in vivo fatty acid manipulation.
Erickson KL; Thomas IK
J Natl Cancer Inst; 1985 Aug; 75(2):333-40. PubMed ID: 3860685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
